MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Visual hallucination and pattern of brain degeneration in Parkinson’s disease

    W.W. Lee, E.J. Yoon, J.Y. Lee, S.W. Park, Y.K. Kim (Seoul, Korea)

    Objective: This study was aimed to reveal pattern of brain degeneration related to visual hallucination (VH) throughout different stages of PD. Background: Previous neuroimaging studies…
  • 2016 International Congress

    Changes of brain structure and cognition in individuals with possible prodromal Parkinson’s disease

    M. Heldmann, J. Heeren, L. Rauch, C. Klein, T.F. Münte, M. Kasten, N. Brüggemann (Lübeck, Germany)

    Objective: Investigating brain structure and cognition in healthy individuals with positive Parkinson's disease (PD) risk markers (hyposmia, increased hyperechogenic area of the substantia nigra). Background:…
  • 2016 International Congress

    The efficacy of quantitative 99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease

    C.F. Lee, C.Y. Wei, G.U. Huang, I.J. Chen, B. Hsu (Changhua, Taiwan)

    Objective: We aim to establish the normal reference with quantitative 99mTc-Trodat-1 (TRODAT) SPECT and verify the diagnostic performance in aged Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    Detecting brainstem changes in Parkinson’s disease using quantitative MRI

    C. Lambert, A. Lutti, B. Draganski, T. Foltynie (London, United Kingdom)

    Objective: 1. Can brainstem changes be detected using quantitative MRI (qMRI). 2. How many subjects would be required to detecting changes in brainstem regions affected…
  • 2016 International Congress

    Neuron specific protein S100B and cognitive impairment in various forms parkinsonism

    R.J. Matmurodov, K.M. Khalimova, N.S. Rashidova, U. Ergashev, O. Turgunhojayev (Tashkent, Uzbekistan)

    Objective: In Parkinson's disease (PD) in almost all patients at the early stages of developing cognitive impairment. Background: Study of the degree of cognitive impairment,…
  • 2016 International Congress

    Participation in cognitively-stimulating activities and computer use are associated with better cognitive performance in Parkinson’s disease independent from nigrostriatal dopaminergic and cortical cholinergic degenerations

    J.L.B. Bohnen, M.L.T.M. Muller, J.D.J. Haugen, N.I. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between times spent with cognitively stimulating activities and cognitive functions in Parkinson's disease (PD) while accounting for the degree of…
  • 2016 International Congress

    How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study

    A. Meyer, U. Gschwandtner, V. Cozac, F. Hatz, P. Fuhr (Basel, Switzerland)

    Objective: (1) To ascertain the evolution of neuropsychological profile of PD patients with stable cognition (non-converter) in comparison to PD patients with a decline (converters)…
  • 2016 International Congress

    Feasibility and effectiveness of a low-threshold psychoeducative group-intervention for depression in Parkinson’s disease

    K. Linse, M. Fauser, C. Ossig, A. Hermann, A. Storch (Dresden, Germany)

    Objective: To evaluate a low-threshold psychoeducative group-intervention for depression in idiopathic Parkinson's disease (PD). Background: Up to 40% of PD-patients suffer from clinically relevant depression…
  • 2016 International Congress

    Comparative study patients with different clinical forms of Parkinson’s disease

    N.D. Demchuk, T.V. Yakovleva, Y.V. Karakulova (Perm, Russia)

    Objective: To study the cognitive, emotional status, sleep disturbances in patients with akinetic-rigid and tremor form of Parkinson's disease (PD). Background: Parkinson's disease (PD) -…
  • 2016 International Congress

    Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration: Results of a large international multicenter study of 3206 patients (the QUALPD study)

    M. Skorvanek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gershanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))

    Objective: To analyze the MDS-UPDRS part I-IV scores and their differences based on Hoehn and Yahr stage (HY) and disease duration in a large cohort…
  • « Previous Page
  • 1
  • …
  • 382
  • 383
  • 384
  • 385
  • 386
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley